SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-15-070554
Filing Date
2015-12-11
Accepted
2015-12-11 16:30:21
Documents
4
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v426600_10qa.htm 10-Q/A 36418
2 EXHIBIT 10.1 v426600_ex10-1.htm EX-10.1 497117
3 EXHIBIT 31.1 v426600_ex31-1.htm EX-31.1 9955
4 EXHIBIT 31.2 v426600_ex31-2.htm EX-31.2 9680
  Complete submission text file 0001144204-15-070554.txt   554420
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33357 | Film No.: 151283599
SIC: 2836 Biological Products, (No Diagnostic Substances)